mBioMicrobiologyPeer-reviewed journal article
The Chlamydia trachomatis secreted effector protein CT181 binds to Mcl-1 to prolong neutrophil survival
Robert FarisiD, Rebecca Koch, Paige N. McCaslin, Naveen ChallagundlaiD, Brianna P. SteiertiD, Shelby E. AnderseniD, Alix McCulloughiD, Parker N SmithiD, C.A. Jabeena, Peter M. YauiD, Thomas RudeliD, Mary M. WeberiD
Abstract
Chlamydia trachomatis (C.t) infections can lead to severe complications due to the pathogens ability to evade the host immune response, often resulting in asymptomatic infections. The mechanisms underlying this immune subversion remain incompletely understood but likely involve specific bacterial effector proteins. Here, we identify CT181 as a novel effector that directly binds to Mcl-1, a key regulator of neutrophil survival. While a C.t. CT181 mutant exhibited only modest defects in epithelial cell replication and inclusion development, it was essential for C.t. survival in neutrophils, correlating with Mcl-1 stabilization. Using a murine infection model, we demonstrate that CT181 is required for C.t. colonization and cytokine production in vivo. Our findings establish CT181 as the first bacterial effector protein known to bind Mcl-1 to enhance neutrophil survival, revealing a critical strategy by which C.t. promotes immune dysregulation, facilitating bacterial persistence while driving C.t. pathogenesis.
- Citations
- 2
- FWCI
- 8.52
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Chlamydia trachomatis secreted effector CebN targets nucleoporins and Rae1 to antagonize STAT1 nuclear import
Brianna P. Steiert, Cherilyn A. Elwell, … Mary M. Weber·bioRxiv·Apr 25, 2024
- IFNγ insufficiency during mouse intravaginal Chlamydia trachomatis infection exacerbates alternative activation in macrophages with compromised CD40 functions
N. Challagundla, D. Shah, … R. Agrawal-Rajput·bioRxiv·Jul 5, 2022
- The Chlamydia trachomatis Inc Tri1 interacts with TRAF7 to displace native TRAF7 interacting partners
C. Herrera, E. McMahon, … J. Engel·bioRxiv·Feb 26, 2024
- Seminal plasma inhibits Chlamydia trachomatis infection in vitro, and may have consequences on mucosal immunity
- Divergent myelopoiesis and macrophage polarization underlie host susceptibility to chronic Chlamydia trachomatis infection
Naveen Challagundla, Shivani Yadav, Reena Agrawal-Rajput·bioRxiv·Dec 13, 2025
- Chlamydia trachomatis effector Dre1 interacts with dynactin to reposition host organelles during infection